BIOMAT Database Logo BIOMAT Database Logo

Carboplatin and vinorelbine in the treatment of advanced non-small-cell lung cancer: a multicenter phase II study. 1998

C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Department of Pneumology, Azienda Ospedaliera Careggi, Florence, Italy.

The aim of this study was to identify a chemotherapy combination that would be active and well tolerated for palliative treatment of advanced non-small-cell lung cancer (NSCLC). From February 1992 to December 1994, a total of 77 patients affected by stage-IIIB and stage-IV NSCLC were treated with carboplatin 350 mg/m2 on day 1 and vinorelbine 25 mg/m2 on days 1 and 8 of each cycle, with cycles repeated every 28 days. All patients were evaluable for response and toxicity. A total of 24 patients showed a partial response (31% response rate; 95% CI = 21-41%). The median duration of overall survival was 41 weeks (95% CI = 31-51), and the median time to disease progression was 34 weeks (95% CI = 25-43). The treatment was well tolerated: no grade-4 toxicity was observed. The carboplatin-vinorelbine combination deserves to considered as a valid alternative to regimens that include cisplatin for palliative treatment of advanced NSCLC.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077235 Vinorelbine A vinca alkaloid related to VINBLASTINE that is used as a first-line treatment for NON-SMALL CELL LUNG CANCER, or for advanced or metastatic BREAST CANCER refractory to treatment with ANTHRACYCLINES. 5'-Nor-anhydrovinblastine,KW 2307,KW-2307,Navelbine,Vinorelbine Tartrate,5' Nor anhydrovinblastine,KW2307
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Carboplatin and vinorelbine in advanced non-small cell lung cancer: a phase I/II study.
January 2001, The oncologist,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Carboplatin, ifosfamide, and vinorelbine in the treatment of advanced non-small-cell lung cancer: a phase II study.
February 1999, American journal of clinical oncology,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
December 2001, Lung cancer (Amsterdam, Netherlands),
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer.
June 1995, Lung cancer (Amsterdam, Netherlands),
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Randomized phase II study of paclitaxel and carboplatin or vinorelbine in advanced non-small cell lung cancer.
January 2011, Anticancer research,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Vinorelbine and carboplatin in inoperable non-small cell lung cancer: a monoinstitutional phase II study.
January 2003, Oncology,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Carboplatin and vinorelbine in advanced non-small-cell lung cancer.
January 1996, Cancer chemotherapy and pharmacology,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study.
May 2004, Cancer chemotherapy and pharmacology,
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Amifostine plus cisplatin plus vinorelbine in the treatment of advanced non small cell lung cancer: a multicenter phase II study.
June 2000, Lung cancer (Amsterdam, Netherlands),
C Santomaggio, and E Tucci, and M Rinaldini, and R Algeri, and R Righi, and F Pepi, and P Ghezzi, and A Andrei, and A Bellezza
Phase II study of concurrent chemoradiotherapy with carboplatin and vinorelbine for locally advanced non-small-cell lung cancer.
May 2014, Molecular and clinical oncology,
Copied contents to your clipboard!